Pollogen’s TriLipo Technology to be Presented at the Upcoming World Congress of Dermatology 2011

May 17, 2011

TriLipo® by Pollogen will be presented at the World Congress of Dermatology 2011 in Seoul, Korea by Dr. Jonathan Yu. The lecture highlights the safety and efficacy in the treatment of circumference reduction, improvement of cellulite appearance and skin tightening as well as facial skin tightening and wrinkles reduction.

(PRWEB) May 15, 2011

Pollogen Ltd., a global leader in the medical aesthetics market, announced today that it will present its TriLipo® technology at the World Congress of Dermatology (WCD) in Seoul, Korea taking place May 25th-29th, 2011.

Jonathan Yu, MD, FPDS, a renowned dermatology expert, will lecture on “Body shaping using the Maximusâ“¢ device based on the TriLipo® Technology”. The lecture will take place on May 28, 8:15-9:45 as part of the FC 21 Laser III session.

Non-invasive aesthetic procedures for body shaping are constantly demanded worldwide. Currently existing non- invasive procedures are limited in term of efficacy and safety and practitioners often tend to combine a few technologies and complementary treatment modalities in order to improve results.

The TriLipo technology offers a new approach by combining two technologies delivered simultaneously: Focused TriLipo RF for thermal effect and TriLipo DMA for internal muscles activation.

Clinical evaluations of the technology demonstrate its safety and efficacy in the treatment of circumference reduction, improvement of cellulite appearance and skin tightening as well as facial skin tightening and wrinkles reduction.

Patients and practitioners benefit from the use of simultaneous multiple technologies at once, in a significantly shorter treatment time as compared to other commonly used combination protocols applying separate devices or technologies.

The novel technology provides a unique non-invasive alternative to surgical treatments for body shaping. Following the treatment, patients experience visible immediate and long-lasting results. The body contouring is achieved by reducing and removing subcutaneous fat and skin tightening via collagen remodeling. The treatment is suitable for body and facial areas in patients of all skin types.

Dr. Yu stated: “Reaching superior body contouring and facial rejuvenation results is of the utmost importance to my patients and I. I have been using Pollogen’s non-invasive body shaping systems for many years as they deliver impressive results on a regular basis. The new TriLipo technology impressed me more than any other non-invasive treatment I have seen so far. It enables me to simultaneously treat the dermis, fat and muscles. The patients I’ve treated reached wonderful immediate and long-lasting results and were pleasantly surprised with the pain-free, quick treatment.”

Mr. Bar-Nir, Pollogen’s CEO commented: “At Pollogen, we are constantly growing, creating new technologies and expanding our product-line. We are very pleased with our latest innovation – TriLipo technology which is available in our newest flagship medical aesthetic device, the Maximus. It is a great honor for Pollogen that Dr. Jonathan Yu is presenting his excellent results and personal experience with our TriLipo technology at the World Congress of Dermatology.”

About Pollogen:

Pollogen Ltd. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for women and men that enhance and expand the practice of medical aesthetics professionals. The company offers products to address a range of skin treatments under the industry’s two premier brands: TriPollar® and TriLipo®. Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for circumference reduction, cellulite reduction and skin tightening. The flagship medical aesthetic devices, Maximus, apollo and regen XL offer customers clinically-proven, safe and effective anti-aging lunch time beauty treatments that deliver immediate and long-lasting results.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebTriLipo/Pollogen/prweb8413640.htm

Source: prweb

comments powered by Disqus